The 1st International Workshop on Myelodysplastic Syndromes (iwMDS) 2022 was held in Miami, FL, and brought together leading experts in MDS who discussed the latest updates in the field. Several fascinating topics were covered at this year’s meeting, including immune dysregulation and targeting in MDS, improving the efficiency of drug approvals, treating high-risk disease, and more.
In this podcast, Amer Zeidan, MBBS, Yale School of Medicine, New Haven, CT, Rena Buckstein, MD, FRCPC, Sunnybrook Health Sciences Centre, Toronto, Canada, and Valeria Santini, MD, University of Florence, Florence, Italy, share key highlights from this year’s workshop. The experts comment on the importance of improving clinical trial design and therapeutic options for patients, as well challenges in the field.
The post iwMDS 2022: Key highlights appeared first on VJHemOnc.
